Pascal M Frey1, Marie Méan2, Andreas Limacher3, Waltraud Leiss4, Nathalie Schwab4, Mathilde Rochat5, Drahomir Aujesky4. 1. Department of General Internal Medicine, Bern University Hospital, Bern, Switzerland. Electronic address: pascal.frey@insel.ch. 2. Department of General Internal Medicine, Bern University Hospital, Bern, Switzerland; Department of General Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland. 3. CTU Bern, Department of Clinical Research, and Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland. 4. Department of General Internal Medicine, Bern University Hospital, Bern, Switzerland. 5. Department of General Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland.
Abstract
BACKGROUND: The Pulmonary Embolism Quality of Life questionnaire (PEmb-QoL) is a 40-item questionnaire to measure health-related quality of life in patients with pulmonary embolism. It covers six 6 dimensions: frequency of complaints, limitations in activities of daily living, work-related problems, social limitations, intensity of complaints, and emotional complaints. Originally developed in Dutch and English, we prospectively validated a German version of the PEmb-QoL. METHODS: A forward-backward translation of the English version of the PEmb-QoL into German was performed. German-speaking consecutive adult patients aged ≥18 years with an acute, objectively confirmed pulmonary embolism discharged from a Swiss university hospital (01/2011-06/2013) were recruited telephonically. Established psychometric tests and criteria were used to evaluate the acceptability, reliability, and validity of the German PEmb-QoL questionnaire. To assess the underlying dimensions, an exploratory factor analysis was performed. RESULTS: Overall, 102 patients were enrolled in the study. The German version of the PEmb-QoL showed a good internal consistency (Cronbach's alpha ranging from 0.72 to 0.96), item-total (0.53-0.95) and inter-item correlations (>0.4), and test-retest reliability (intra-class correlation coefficients 0.59-0.89) for the dimension scores. A moderate correlation of the PEmb-QoL with SF-36 dimension and summary scores (0.21-0.83) indicated convergent validity, while low correlations of PEmb-QoL dimensions with clinical characteristics (-0.16-0.37) supported discriminant validity. The exploratory factor analysis suggested four underlying dimensions: limitations in daily activities, symptoms, work-related problems, and emotional complaints. CONCLUSION: The German version of the PEmb-QoL questionnaire is a valid and reliable disease-specific measure for quality of life in patients with pulmonary embolism.
BACKGROUND: The Pulmonary Embolism Quality of Life questionnaire (PEmb-QoL) is a 40-item questionnaire to measure health-related quality of life in patients with pulmonary embolism. It covers six 6 dimensions: frequency of complaints, limitations in activities of daily living, work-related problems, social limitations, intensity of complaints, and emotional complaints. Originally developed in Dutch and English, we prospectively validated a German version of the PEmb-QoL. METHODS: A forward-backward translation of the English version of the PEmb-QoL into German was performed. German-speaking consecutive adult patients aged ≥18 years with an acute, objectively confirmed pulmonary embolism discharged from a Swiss university hospital (01/2011-06/2013) were recruited telephonically. Established psychometric tests and criteria were used to evaluate the acceptability, reliability, and validity of the German PEmb-QoL questionnaire. To assess the underlying dimensions, an exploratory factor analysis was performed. RESULTS: Overall, 102 patients were enrolled in the study. The German version of the PEmb-QoL showed a good internal consistency (Cronbach's alpha ranging from 0.72 to 0.96), item-total (0.53-0.95) and inter-item correlations (>0.4), and test-retest reliability (intra-class correlation coefficients 0.59-0.89) for the dimension scores. A moderate correlation of the PEmb-QoL with SF-36 dimension and summary scores (0.21-0.83) indicated convergent validity, while low correlations of PEmb-QoL dimensions with clinical characteristics (-0.16-0.37) supported discriminant validity. The exploratory factor analysis suggested four underlying dimensions: limitations in daily activities, symptoms, work-related problems, and emotional complaints. CONCLUSION: The German version of the PEmb-QoL questionnaire is a valid and reliable disease-specific measure for quality of life in patients with pulmonary embolism.
Authors: Nicoletta Riva; Christian Borg Xuereb; Michael Makris; Walter Ageno; Alex Gatt Journal: Patient Prefer Adherence Date: 2019-06-19 Impact factor: 2.711
Authors: Simone Fischer; Christine Meisinger; Jakob Linseisen; Wolfgang von Scheidt; Thomas M Berghaus; Inge Kirchberger Journal: Qual Life Res Date: 2022-03-14 Impact factor: 4.147
Authors: Luca Valerio; Anna C Mavromanoli; Stefano Barco; Christina Abele; Dorothea Becker; Leonhard Bruch; Ralf Ewert; Martin Faehling; David Fistera; Felix Gerhardt; Hossein Ardeschir Ghofrani; Aleksandar Grgic; Ekkehard Grünig; Michael Halank; Matthias Held; Lukas Hobohm; Marius M Hoeper; Frederikus A Klok; Mareike Lankeit; Hanno H Leuchte; Nadine Martin; Eckhard Mayer; F Joachim Meyer; Claus Neurohr; Christian Opitz; Kai Helge Schmidt; Hans Jürgen Seyfarth; Rolf Wachter; Heinrike Wilkens; Philipp S Wild; Stavros V Konstantinides; Stephan Rosenkranz Journal: Eur Heart J Date: 2022-09-21 Impact factor: 35.855
Authors: Christa Meisinger; Jakob Linseisen; Inge Kirchberger; Wolfgang von Scheidt; Thomas M Berghaus Journal: BMJ Open Date: 2019-10-28 Impact factor: 2.692
Authors: Roisin Bavalia; Ingrid M Bistervels; Wim G Boersma; Isabelle Quere; Dominique Brisot; Nicolas Falvo; Dominique Stephan; Francis Couturaud; Sebastian Schellong; Jan Beyer-Westendorf; Karine Montaclair; Waleed Ghanima; Marije Ten Wolde; Michiel Coppens; Emile Ferrari; Olivier Sanchez; Patrick Carroll; Pierre-Marie Roy; Susan R Kahn; Karina Meijer; Simone Birocchi; Michael J Kovacs; Amanda Hugman; Hugo Ten Cate; Hilde Wik; Gilles Pernod; Marie-Antoinette Sevestre-Pietri; Michael A Grosso; Minggao Shi; Yong Lin; Barbara A Hutten; Peter Verhamme; Saskia Middeldorp Journal: Res Pract Thromb Haemost Date: 2021-07-14